Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac pw1+ stromal cells

HIGHLIGHTS

• who: Marion Bouvet from the Universitée of Cardio Metabolism and Nutrition (ICAN), Paris, FranceUniversity of have published the research work: Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cells, in the Journal: Scientific Reports Scientific Reports of 14/02/2020
• what: Here the authors provide the first description of the proteins expressed on the surface of cardiac ­PW1+ cells and identify a novel target to suppress the fibrogenic behavior of these cells, resulting in favorable outcomes in post-MI cardiac remodeling and animal survival.
• how . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.